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真菌，并对这 21 株真菌的发酵液粗提物进行了细胞毒活性的检测（采用 CCK-8
试剂盒），从中得到四株具有较好的细胞毒活性的菌株。然后，对活性 好的菌




















































Along with industrial pollution and the growing environmental damage, the 
incidence of malignant tumor is gradually increased year by year, while the 
conventional antitumor drugs also have significant side effects. As the result, the 
development of antitumor drugs and the detecting of novel targets for antitumor drug 
have become the vital research projects in life science area. As we know, deep sea 
environment with high-pressure, low temperature, few nutritional characteristics 
usually makes those microorganisms which live in it develop a series of complex and 
divesal metabolic pathways in order to survive and adapt to the special environment. 
Those complex and divesal metabolic pathways provide rich resources for the 
screening of antitumor compounds. Among them, the deep-sea fungi not only have 
the universal particularity of deep-sea microbs, but also have complex metabolic 
pathways of fungi themselves. Besides, the research of antitumor drugs from deep-sea 
fungi is still rare. So, this research has a promising prospect. 
In this research task, 21 deep-sea fungi were separated and identified from the 
deep-sea sediments of the 19th ocean voyage, and the cytotoxicity of the fermental 
crude extracts of the 21 strains were detected using the CCK-8 kits and four strains 
with high cytotoxic activity were found. Then the 60L fermentation was carried out 
for strain F11（Penicillium sp.）, and the the F1120, which is the main component of 
F11 fermentation, was separated and purified by chemical methods. By detecting of 
cytotoxicity, the F1120 is proved to be with high activity. Meanwhile, by means of 
MS and NMR, the structure of this compound is identified as Secalonic Acids F.  
   In view that there is a few international researches on the cytotoxicity of this 
compound and almost none report about its antitumor mechanism, this article carried 
out the primary research on its antitumor mechanism by the method of proteomics, 
that is analyzing the variances of proteins of HL60 cells with 0h, 24h and 48h 
















found to be changed apparently, with 7 spots downgraduated and 13 spots upregulated. 
Among them, 7 spots got the credible results (P<0.05) after sending those 20 spots to 
Shang hai Chinese academy of sciences protein center for MS analysis.  
Through literature review, two significant upregulated proteins, which are 
nucleophosmin (NPM) and Ran-specific GTPase-activating protein (Ran GAP), are 
found to be related to the formation of malignant tumor. Particularly, nucleolar protein 
phosphorylation, which is one of the major proteins located in nucleolar granular zone, 
could shuttle in the nucleolus, nucleus and cytoplasm and participate in the 
transportion of the precursors of ribosome and centrosome replication and then 
regulate cell cycle progression and proliferation of development. NPM which are 
expressed in the proliferation of active cells, including tumor cells and stem cells, 
play an important role in tumor formation. NPM gene is often highly expressed in 
tumor cells, resulting in the excessive nucleophosmin and promoting cell malignant 
proliferation and resistance to apoptosis. So the significant downregulation of this 
protein is likely to result in the death of tumor cells and the following work can be 
carried out on this protein.   


















恶性肿瘤极大的危害着人类的健康。在 1991 年到 2000 年间，全球癌症发病
及死亡人数均增长 22%。2002 年世界新发肿瘤人数 1100 万，当年死亡病例达到






























































































Belofsky 等[9]从加勒比海绿藻 Penicillus capitatus 体表中分离出的 Aspergillus 
versicolor 中得到 4 个倍半萜硝基苯酯化合物，它们对体外 HCT-116 细胞有活性，
也对不同的肾脏肿瘤细胞系有中强度的选择性细胞毒活性。Nakagawa[10]从
Myrotheciumv errucaria 中分离出五环二萜 myrocin（C20H24O5），实验表明该化合
物具有抑制艾氏腹水瘤活性的作用。 
(2) 肽类化合物 
Mercedes Cueto 等[11]从海藻 Avrainvillea sp.中分离出镰孢属真菌 Fusariu 
sp.(CNL-619) ， 并 从 其 发 酵 液 中 分 离 得 到 1 个 环 五 肽 类 化 合 物
N-methylsansalvamid，对NCI人类癌细胞株具有增殖抑制活性(GI50为8.3μmol/L)，
而与其结构类似的 sansalvamide 在 NCI 人类癌细胞株筛选中表现出中等程度的
增殖抑制活性(GI50 为 3.6μmol/L) [12]。Fenical 等[13]从采自巴布亚新几内亚的绿藻


















下 15 米处的绿藻表面分离到海藻真菌 Scytalidium sp.，并从其发酵液中分离到两
种环七肽类化合物。这两种环七肽化合物对 MOLT-4 白血病细胞和 Uacc-257 黑
色素瘤细胞都具有很强的抑制作用。加利福尼亚大学的 William Fenical 等人[15]
在一种来源于拉奈岛的海洋蓝藻菌聚积体 Cyanobacterial mat 中分离得到真菌
Exserohilum rostratum，其发酵产物经色谱分离、结构鉴定，得到 4 个新的过硫
环二肽化合物 rostratins A-D。体外活性测试表明，rostratins A-D 对人结肠癌细胞
HCT-116 有细胞毒活性，其 IC50分别为 8.5， 1.9， 0.76 和 16.5 mg/L。 
(3) 生物碱类化合物 
Hochlowski 等人[16]报道从 Aspergillus fischeri 的一个新菌株 var.brasiliensis
的发酵液和菌丝体中分离得到 3 个吲哚生物碱，可以显著降低肿瘤细胞对抗肿瘤
药物的抗药性。 Wagenaar 等 [17] 从植物雷公藤中分离了一种内生真菌
Rhinocladiella sp.，发现其产生三种结构新颖的胞松素类生物碱。Amagata 等[18]
从 Halichonbolria sponge 中分离到一株新的菌株 Gymnascella sp.，其代谢产物
gymnstatins A-E 对白血病系细胞 P388 均有较强的抑制活性。Tsuda 等[19]从采自
日本冲绳岛边户岬的一种红藻 Actinotrichia fragilis 中分离得到一株青霉属真菌
Penicillium citrinum，在其代谢产物中分离到一个结构新颖的五环生物碱类化合
物 Citrinadin A。该化合物对小鼠白血病细胞 L1210 和人表皮癌细胞 KB 均有抑
制作用。 
(4) 其他类化合物 
Amagata等人[20]从 Trichoderma harzianum OUP-N115的培养液中分得 3个环
戊烯酮化合物 Trichodenone A（C7H8O2）、B（C7H9O3Cl）、C（C7H9O2Cl），实验
显示该类化合物对肿瘤细胞 P388 有显著的细胞毒活性。Gerwick 研究小组[21]则
从加勒比海真菌 Lyngbra majuscula 中分得了酰胺类化合物 CuracinA，CuracinA
具有抗有丝分裂和抗肿瘤活性，特别是对人类乳腺癌细胞具有较强的抑制作用。
Shiozawa 等[22]从 Talaromyces trachysperms SANK12191R 的培养液中分得一个新
的三羧酸类化合物 Trachypic acid（C20H28O9），该化合物对肿瘤细胞中的类肝素
















得一个二苯基甲烷化合物 GRE1-BP002-A，其对 HCT-15 等多种肿瘤细胞都有细














































繁殖的兼性海洋真菌。目前已经发现了高等海洋真菌 244 属 477 种[26]，包括子




于深海沉积物、贝类中的真菌，发现了 Aspergillus 属的耐嗜压真菌。Turley C M
等[29]自 4500 米身深的西北大西洋分离到目前唯一的极端嗜压真菌，属于 Bodo 









活性。产生这些新天然产物的真菌以Aspergilli 和 Penicillia属真菌 为常见，这
可能是由于该两属菌均为耐盐菌，繁殖旺盛，故而容易从不同生长基物中分离到。
这些真菌大多数来源于海绵28% 和海藻27% ，来自海洋沉积物的较少4% 。 
2004年，Gautschi JT等 [34]从两株来自1335米的深海沉积物的青霉菌
Penicillium Corylophilum混合发酵物中分离到两个已知的戊烯酮类色素
anserinones A 、 B 及 3 个 新 结 构 的 类 似 化 合 物 (+)-formylanserinone B, 
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